Herbalife Ltd. outlined full-year 2026 adjusted EBITDA guidance of $670 million to $690 million on a reported basis while announcing that CFO John DeSimone will retire at year-end and be succeeded by Scott Schaefer at the start of 2027. Second-quarter net sales rose 5.4% to $1.3 billion, at the top end of guidance, and adjusted EBITDA reached $167 million, also at the high end of its range. The company narrowed its full-year net sales growth outlook to 2.5% to 5.5% on both a reported and constant currency basis, and it still targets a net leverage ratio below 2x by year-end. The quarter included a GAAP net loss of $26 million driven by a nearly $95 million pretax loss on debt extinguishment, while operating cash flow for the first half of 2026 jumped 52% to $147 million. Management highlighted the launch of Bioniq Go personalized supplements and the continued beta expansion of the Pro2col platform as key strategic milestones.
Herbalife Nutrition LtdCompany provides 2026 EBITDA guidance above expectations and strong Q2 results, though CFO transition noted.
